Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01583725 · ClinicalTrials.gov registry record · NA

fMRI and Appetite-Related Hormones Pre and Post Obesity Surgery

A NA study, sponsored by New York Obesity and Nutrition Research Center.

Completed
Registry status
NA
Development phase
120
Enrollment target

NCT01583725: Completed NA study, sponsored by New York Obesity and Nutrition Research Center.

NCT01583725 is a NA study that has completed, run by New York Obesity and Nutrition Research Center. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01583725, a NA study, has completed, sponsored by New York Obesity and Nutrition Research Center.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

The investigators are looking at the differences in appetite and obesity between weight loss participants and patients undergoing bariatric surgery. Obese persons between the ages of 18 \& 65 are eligible to participate in this study, whether or not they intend to undergo bariatric surgery.

Primary Outcome

Measures of brain brain activation in areas associated with food reward and motor planning, including the orbitofrontal cortex (OFC). Over the course of 40-min fMRI scans, we will compare change in activation from 3 mo pre-surgery to 3 and 18 mo post-surgery, and predict a post-surgical decrease in activation in such regions.

Interventions

  • PROCEDURE Liquid meal responses
  • BEHAVIORAL fMRI responses to food-cues

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2010-07
Est. Completion 2015-07
Phase NA

What the finished NCT01583725 record still lists

NCT01583725 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Liquid meal responses is the first listed.

NCT01583725 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01583725 about?

NCT01583725 is a clinical study titled "fMRI and Appetite-Related Hormones Pre and Post Obesity Surgery". The investigators are looking at the differences in appetite and obesity between weight loss participants and patients undergoing bariatric surgery. Obese persons between the ages of 18 \& 65 are eligible to participate in this study, whether or not they intend to undergo bariatric surgery.

What is the current status of trial NCT01583725?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2010-07. Estimated completion is 2015-07.

What interventions are being tested in trial NCT01583725?

The interventions under investigation include: Liquid meal responses (PROCEDURE), fMRI responses to food-cues (BEHAVIORAL).

Who is sponsoring clinical trial NCT01583725?

This trial is sponsored by New York Obesity and Nutrition Research Center, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01583725's enrollment target sits among peer trials

120 762nd of 2000 higher than 1,198 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01583725, the US trial registry maintained by the National Library of Medicine. NCT01583725 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.